Core Viewpoint - Beijing Resources (00618) has reported a significant turnaround in its financial performance for the six months ending September 30, 2025, achieving a profit of approximately RMB 1.88 billion, driven by strategic asset sales and a focus on core business areas [1] Financial Performance - The company achieved total revenue of approximately RMB 810 million, representing a year-on-year growth of 8.1% [1] - The profit turnaround was primarily due to the sale of certain property development projects, generating approximately RMB 2.31 billion in revenue [1] - The company has improved its financial health, with interest-bearing loans reduced to RMB 253 million and a current ratio improved to 1.29 [1] Business Focus - The company has optimized its business structure, concentrating on two core areas: healthcare and pharmaceutical retail, as well as e-commerce and distribution [1] - E-commerce revenue reached RMB 430 million, reflecting a year-on-year increase of 37.1% [1] - The healthcare and pharmaceutical retail segment generated approximately RMB 70 million in revenue, with initiatives to advance the "pharmacy + traditional Chinese medicine" model and digital transformation [1] Corporate Actions - In August 2025, the company completed the establishment of a partnership with a third party, injecting certain property projects and streamlining its organizational structure to reduce liabilities [1] - The board of directors has decided not to recommend the distribution of an interim dividend [1]
北大资源（00618.HK）发布2025中期报告，12月23日股价上涨2.14%